Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Potassium permanganate
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Potassium permanganate 400mg tablets for cutaneous solution
1311060Q0AAACAC
|
Potassium permanganate | Potassium permanganate | Skin | 2,136 |
|
Permitabs 400mg tablets for cutaneous solution
1311060Q0BBAAAC
|
Permitabs | Potassium permanganate | Skin | 205 |
|
EN-Potab 400mg tablets for cutaneous solution
1311060Q0BCAAAC
|
EN-Potab | Potassium permanganate | Skin | 1 |
|
Potassium permanganate 0.01% topical solution
1311060Q0AAALAL
|
Potassium permanganate | Potassium permanganate | Skin | 1 |
|
AnateP 400mg tablets for cutaneous solution
1311060Q0BDAAAC
|
AnateP | Potassium permanganate | Skin | No data available |
|
Potassium permanganate 0.1% topical solution
1311060Q0AAABAB
|
Potassium permanganate | Potassium permanganate | Skin | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.